Study of Tumor Progression in vivo and in vitro using
Study of Tumor Progression in vivo and in vitro using
批准号:
06671186
负责人:
TAKEDA Yasutaka
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Five autonomous sublines, T4-OI320 (329), T4-OI320CY (320CY), T4-OI165 (165), T4-OI145 (145), and T4-OI96 (96), were established from the transpalantable hormone-dependent mouse mammary tumor, TPDMT-4 (T4), by passaging under different conditions. These autonomous tumors were characterized by rapid growth in DDD virgin mice and the parental T4 by no growth in them. Thus, 10^5320,210^4320CY,2*10^3165,2*10^3145 and 10^396 cells were co-injected with 5*10^5T4 cells into virgin mice to determine whether hormone-dependent tumor cells influence the growth of autonomous tumor cells or not. T4 cells retarded the growth of 320 and 320CY tumors but accelerated that of 165,145 and 96. Irradiated T4 cells stimulated the growth of all the sublines but 320. In three-dimensional collagen gel culture, 320 and 320CY cells formed branched or stellate structures similar to normal mammary glands as did T4, but 165,145 and 96 cells grew as rounded masses with knobs and showed completely different morphology. 165,145 and 96 cells but not the others had lung-colonizing capability. In the collagen gel culture system, an antibiotic protease inhibitor exerted a stronger growth-inhibiting effect on the metastatic than on the parent and non-metastatic tumors. Thus, the susceptibility of autonomous subline tumor cells to the growth-inhibitory regulation from the parenetal hormone-dependent tumor cells was well correlated with growth morphology within collagen gels and metastatic property. The results suggest that metastatically-competent tumor cell variants, once they appear, may have a growth advantage in hormone-dependent mammary tumors. Application of this in vitro sytem to human breast cancer is in progress.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
武田泰隆、松澤昭雄: "マウス正常乳腺上皮、ホルモン依存性乳癌および非依存性乳癌に及ぼすlysophosphatidic acidの影響についての検討." 乳癌基礎研究. (印刷中).
Yasutaka Takeda、Akio Matsuzawa:“溶血磷脂酸对小鼠正常乳腺上皮、激素依赖性乳腺癌和非依赖性乳腺癌的影响的研究(正在出版)。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Matsuzawa, A. and Takeda, Y.: "Establishment of tumor dormant state following clinically complete cure of disseminated leukemia by chemotherapy in mice." In "Premalignancy and Tumor Dormancy" eds. R. H. Scheuermann and E. Yefenof. R. G. Landes Company, Ge
Matsuzawa, A. 和 Takeda, Y.:“通过小鼠化疗临床完全治愈播散性白血病后,建立肿瘤休眠状态。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Matsuzawa,A,Nakano,H,Sakamoto,S,Yoshimoto,T: "Dramatic hyperplasia of Mtv-2+ lymph node grafts in Mtv-2〜 recipients and selective stimulation of Vβ14+ T cells in recipients'lymph nodes" J.immunol. 154. 1644-1652 (1995)
Matsuzawa,A,Nakano,H,Sakamoto,S,Yoshimoto,T:“Mtv-2〜受者中Mtv-2 +淋巴结移植物的剧烈增生以及受者淋巴结中Vβ14 + T细胞的选择性刺激”J.immunol。 154. 1644-1652 (1995)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sayama, K., Goto, Y., Iguchi, T., Takeda, Y., and Matsuzawa, A.: "Effects of an antibiotic protease inhibitor, actinonin on the growth within collagen gels of non-metastatic and metastatic mouse mammary tumors of the same origin." Cancer Letters. 94. 171-
Sayama, K.、Goto, Y.、Iguchi, T.、Takeda, Y. 和 Matsuzawa, A.:“抗生素蛋白酶抑制剂放线菌素对非转移性和转移性小鼠乳腺肿瘤胶原凝胶内生长的影响
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Y.Takeda,K.Sayama,Y.Saegusa and A.Matsuzawa: "Ditterent interaction in vivo between hormone dependent mammary tumor cells and related autonomous subline tumor cells with diffrent degree of malignacy in mice" Int.J.Oncol.5. 379 (1994)
Y.Takeda、K.Sayama、Y.Saegusa 和 A.Matsuzawa:“小鼠体内激素依赖性乳腺肿瘤细胞与具有不同恶性程度的相关自主亚系肿瘤细胞之间的不同体内相互作用”Int.J.Oncol.5。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 17 条
Basic study for Analysis of Intractable Resistant Tumor Cells and their Overcoming in Cancer Gene Therapy
-
批准号:14571125
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2002
-
负责人:TAKEDA Yasutaka
-
依托单位:
Clinical Application of Tumor-specific Anti-tumor Immunity Induced by Tumor Cells Expressing Fas (CD95) Ligand
-
批准号:13557097
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.83万
-
财政年份:2001
-
负责人:TAKEDA Yasutaka
-
依托单位:
Basic study for. Cancer Gene Therapy by Antitumor Effects Using Fas-Fas Ligand-Mediated Apoptosis
-
批准号:12671144
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2000
-
负责人:TAKEDA Yasutaka
-
依托单位:
A study for cancer gene therapy through Fas-mediated apoptosis
-
批准号:10671099
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:1998
-
负责人:TAKEDA Yasutaka
-
依托单位:
A study on tumor cell/cell interactions using mouse mammary tumor models
-
批准号:08671337
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1996
-
负责人:TAKEDA Yasutaka
-
依托单位:
海外基金